NEW YORK (GenomeWeb) – Contract research organization Helomics and molecular diagnostics firm MDNA today announced a partnership broadening access to MDNA's tests.

As part of the deal, Helomics will promote MDNA's Prostate Core Mitomic Test and its liquid biopsy Prostate Mitomic Test in select US markets. Helomics will also offer the tests in its CLIA-approved clinical laboratory.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.